Cosmetic & Skin
Matrixyl 3000
Also known as Palmitoyl Pentapeptide blend · Pal-GHK + Pal-GQPR · Palmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7 · Matrikine peptide complex
Matrixyl 3000 is a trademarked topical cosmetic ingredient developed by Sederma that combines two lipidated "matrikine" signaling peptides, palmitoyl tripeptide-1 (Pal-GHK) and palmitoyl tetrapeptide-7 (Pal-GQPR). The peptides are designed to mimic fragments of degraded collagen and to modulate interleukin-6 signaling, with the proposed aim of cueing fibroblasts toward extracellular-matrix synthesis while limiting matrix breakdown. Manufacturer and small published human-use studies report reductions in the surface area occupied by wrinkles and improvements in skin tonicity over roughly two months of regular topical use, and a 2024 study examined the combination in a multi-component eye cream. The overall evidence base is modest, consists largely of supplier-sponsored or small panel studies, and outcomes are appearance-focused rather than measures of structural skin change. It is used in over-the-counter cosmetic skincare formulations and is not an approved drug.
Studied / used for
- Investigated for the appearance of fine lines and deep wrinkles
- Studied for supporting skin firmness and tonicity
- Investigated as a signaling cue for fibroblast collagen and elastin synthesis in cosmetic formulations
- Studied for general signs of skin aging in topical anti-aging products
Commonly reported side effects
- Mild application-site redness commonly reported, mainly in sensitive skin
- Occasional itching or transient irritation reported at the application site
- Reports of irritation or sensitization are uncommon
Not medical advice.
This is an educational reference. Peptalk does not recommend, prescribe, endorse, or rate any compound, and provides no dosing information. Do not start, stop, or change any peptide, hormone, supplement, or therapy based on this page. All clinical decisions must be made with your licensed healthcare provider.